Loading viewer...
earnings
Format: PDF earnings
Amgen's Q2 2023 earnings presentation delivered on August 3, 2023, includes forward-looking statements on product performance, acquisitions including Horizon Therapeutics, and financial guidance. The deck covers clinical developments, commercial updates, and strategic initiatives across Amgen's biopharmaceutical portfolio. Risk factors and safe harbor disclosures detail regulatory, manufacturing, and competitive challenges affecting the company's operations.
earnings
13 Pages
Magnite
Global Ship Lease Q2 2016 Earnings Results
earningsearnings
18 Pages
Global Ship Lease
AIG Third Quarter 2022 Financial Results Earnings Presentation
earningsearnings
35 Pages
American International Group